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Abstract 
Neurocardiogenic Syncope, a condition common in young people, is becoming more 
recognized in the Athletic Training profession. The purpose of this discussion is to delve into 
this condition and provide basic knowledge to help the Athletic Trainer manage athletes with 
this condition. The information will be divided into two sections. First, the examination will 
describe N eurocardiogenic Syncope, its presentation, anatomical and physiological causes, 
warning signs and techniques for diagnosis. It will also examine the decreased quality of both 
daily living and performance due to this condition. The last part of the first section will attempt 
to summarize numerous treatment options available to the athlete with N eurocardiogenic 
Syncope. The second section will present a case study of an intercollegiate athlete with this 
condition and its effect on the athlete's performance and overall well being. It is hoped that this 
examination can bring to light a new and challenging condition that is becoming more frequently 
recognized in the Athletic Training profession and to offer suggestions to make the problem 
more manageable. It is also my goal that the information in this paper can be used to improve 
the quality of health care that Athletic Trainers can provide for the athlete with 
Neurocardiogenic Syncope. 
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Introduction 
In many medical professions, ideas and facts are always changing. The field of 
Sports Medicine is no different. As athletes and athletic competition grow stronger every 
day, the Athletic Training profession must stay abreast of each new condition, illness or 
injury that can slow the athlete down. One condition that has recently emerged into the 
spotlight is fainting, or syncope. Syncope is a problem in today's athletic setting because 
it can be indicative of many underlying conditions. It can be a signal of heart problems, 
nutritional problems and several other illnesses. Today's Certified Athletic Trainer must 
be aware of the causes of syncope, the proper treatment, and the proper actions to 
perform in an t~mergency. It is also important that the Athletic Trainer be knowledgeable 
enough about syncopal conditions to be able to educate the athlete. 
One particular type of syncope that is beginning to be more recognized in the 
athletic arena is Neurocardiogenic Syncope. This is a benign condition that stems from 
an orthostatic imbalance between the brain and the heart. More and more athletes are 
learning proper treatment for the condition, however, and are able to continue 
participation. This has a great deal of connotation for the Athletic Trainer. The Athletic 
Trainer must now educate himself or herself on the causes, treatments, and preventative 
measures that need to be taken when dealing with athletes who have neurocardiogenic 
syncope. This recognition and understanding is especially important on the 
intercollegiate level, due to the common pressures present for these elite athletes. 
Especially when working on the Division I level, the Athletic Trainer is responsible for 
keeping athletes playing, ifpossible. Syncope can make that task challenging. Syncope 
contains a broad spectrum of signs and symptoms, treatments, nutritional factors and 
-much more. The purpose of this examination and the following case study is to explain 
the presentation, recognition, anatomical and physiological concerns, prodrome, 
diagnostic techniques and testing, effects of daily living, preparticipation screening and 
treatment options associated with neurocardiogenic syncope. It will also examine the 
implications this information has for the intercollegiate athlete. 
Presentation and Recognition Factors 
For proper and adequate understanding ofthe remaining content of this 
examination of neurocardiogenic syncope, a few concepts must be defined and clarified. 
First, as Basilico notes, it is important to realize that physicians, coaches, and Athletic 
Trainers are used to seeing athletes at their peak levels of fitness and it is hard to believe 
that any underlying cardiac abnormality could exist in any ofthese elite young men and 
women. I When an athlete presents with syncope, however, the possibility of a cardiac 
abnormality must be investigated regardless of how the examiner may feel about the 
health of the athlete. So, just what is syncope? The medical defmition for syncope is a 
sudden and transient loss of consciousness and postural tone with spontaneous recovery.2 
In lay terms, syncope is often called "fainting" or "passing out". A related condition is 
presyncope, which involves the feeling that one is going to lose consciousness without 
ever fully reaching an unconscious state. There are many different types of syncope, as 
will be discussed later, but the one focused on in this paper will be Neurocardiogenic 
Syncope. This condition has many names, including Neurally Mediated Hypotension, 
Vasodepressor Syncope, Vasovagal Attack, and Vasovagal Syncope.3 No matter which 
name is used, however, the condition is a common disorder of autonomic cardiovascular 
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regulation, which presents itself as syncope or presyncope.3 The diagnosis of this 
condition in the general population is fairly new, with it's appearance frrst being 
documented in 1932 by Sir Thomas Lewis.4,5 Lewis used the name vasovagal syncope to 
describe the vasovagal inhibition that occurs during a syncopal episode. 5 
Syncope is more common in the general population than some may realize. As 
Shen reports, syncope will occur at least once in the lifetime of about one third of the 
general population.6 It is quite possible that many of these syncopal episodes may be due 
to neurocardiogenic syncope. The possibility of a syncopal episode, however, is present 
in all humans.4 It is for this reason, as Barbey states, that neurocardiogenic syncope must 
not be seen as a disease, but rather as an inappropriate reaction or reflex to a stress placed 
on the body.4 As Calkins states, most research shows that neurocardiogenic syncope is 
most frequently seen in young adults. The condition is also more commonly seen in 
women than in men.3 Syncope can often occur in the athletic arena, however, and the 
Athletic Trainer must be prepared to recognize the condition. In fact, this condition is the 
most common reason for syncopal episodes in the athletic setting.7 This recognition is 
not easy, however, and can be confused with many other conditions. 
The first step in recognizing neurocardiogenic syncope is recognizing the 
condition's common patterns of presentation. In the athletic arena, an athlete 
experiencing a syncopal episode during play or on the sidelines creates a dramatic scene.7 
This can be especially true at the high school level, where a young child is being watched 
by worried parents. In young athletes, syncopal episodes can be confused with Sudden 
Cardiac Death (SCD). SCD occurs when an athlete collapses and dies suddenly due to a 
heart abnormality. SCD is more well known that syncope, so the unknowing spectator 
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- may automatically assume that the syncopal athlete is in grave danger during a syncopal 
episode.8 The Athletic Trainer and Coach must be prepared to deal with the syncopal 
episode and must be prepared to field questions to those who may overreact to the 
episode. Syncope can be dangerous, however, because of the high risk of secondary 
injury to the athlete. Injuries can occur if the athlete falls down during a syncopal 
episode or if the athlete is playing in a high contact sport.8 There is also a danger of an 
episode occurring while the athlete is away from the field. Driving, for example, can be 
risky if the athlete has a severe case ofneurocardiogenic syncope that is not controlled. 
-
One problem with neurocardiogenic syncope in the athletic setting is the variety 
of times and places in which an episode may occur. As Calkins, Seifert and Morady 
state, syncope may occur in several situations. It may present 1) during or after exercise; 
2) in trained and untrained athletes; 3) in patients who experience neurocardiogenic 
syncope not related to exercise; 4) not related to an exercise stress test; or 5) with or 
without a prodrome (or warning signs).9 In other words, this condition can be seen at 
almost any time, any where, in anyone. Many times neurocardiogenic syncope is related 
to emotional distress, the sight of blood, pain or injury. Some researchers have also 
found that athlc!tes will experience episodes of syncope in clusters. The attacks will 
become more prevalent for a time, and then will die off for a time. 10 It is a "come and 
go" type probl{:m. This makes it even harder to predict episodes and times when the 
athlete will be most affected. 
If the athlete and the Athletic Trainer learn to recognize attacks, many of them 
can be prevented. For example, attacks almost always present when the thorax is in a 
vertical position.4 In other words, the athlete is usually standing up. In many cases, a full 
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_ syncopal episode can be avoided if the athlete is placed in a supine position on a level 
surface. As Barbey notes, however, many times neurocardiogenic syncope attacks 
present at times when it is either impossible or socially unacceptable to assume this 
corrective position.4 This poses obvious problems; the athlete not only has an episode 
but is also highly visible in social surroundings, making the situation difficult and 
uncomfortable for everyone involved. The more the athlete can learn to avoid these 
situations, the better he or she will be able to adjust to the syncopal episodes as they 
occur. 
Another issue that must be addressed before looking at the specific physiological 
details ofneurocardiogenic syncope are the different causes of general syncope. Syncope 
falls into three general categories: 1) Cardiovascular; 2) Noncardiovascular; and 3) 
Unexplained.6 Cardiovascular Syncope involves specific problems with the 
cardiovascular systems, such as heart arrhythmia, cardiomyopathy, congenital heart 
disease and other specific heart problems. Athletes or patients with cardiovascular (also 
known as cardiac) based syncopal conditions have a potentially life-threatening condition 
and should not continue participation. Noncardiovascular Syncope, on the other hand, 
includes conditions like neurocardiogenic syncope. It is not a problem with the heart 
itself, but rather a series of other malfunctions that lead to syncopal episodes. This type 
of syncope is much less dangerous and not known to be fatal in most cases. Unexplained 
Syncope contains conditions that can not be diagnosed despite diagnostic testing. In 
some cases, tht::re is a psychological factor contributing to the syncopal episodes. 11 It has 
been noted that patients under the age of 45 with psychologically based syncope usually 
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-associate the episodes with other symptoms, like headaches. II In any case, constant 
efforts must be made to attempt to fmd a diagnosis for unexplained cases of syncope. 
Anatomical and Physiological Concerns 
The physiological process behind each episode ofneurocardiogenic syncope is 
very complicated and involves several body structures. A basic review of the anatomy 
and physiology involved as presented by Tortora and Grabowski helps with 
understanding of these concepts. First, refer to the diagram of the human heart in 
Appendix A. This diagram shows the movement of blood through the heart and lungs in 
a normal human being. In a normal human, blood is carried to the right atrium from the 
veins. It is then pumped to the right ventricle and then on to the lungs. Oxygenated 
blood returns to the left atrium from the lungs and is pumped into the left ventricle. It is 
the left ventricle which is responsible for pumping the oxygenated blood to the rest of the 
body. If all parts of the cardiovascular system are functioning properly, there is always 
ample blood returning to the heart from the extremities to be pumped through the heart to 
begin the whole process again. The quantity of blood returning to the heart from the 
body is termed venous return. In turn, the amount of blood the heart pumps back out to 
the extremities is termed cardiac output. In short, when venous return decreases, the 
cardiac output will also decrease. The body will have to compensate, ifpossible, by 
adjusting heart rate until venous return can increase again. 12 
In the average person, there is some amount of pressure in the vascular system at 
all times. This pressure on the walls of the blood vessels is generated by the contraction 
of the ventricles and is termed blood pressure. 12 Blood pressure varies according to the 
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_ amount of stress the body is under, due to the increase and decrease in heart rate and 
changes in vaS(:ular constriction levels experienced when stress levels change. For 
example, during exercise, the heart rate will increase to meet the incessant demand for 
oxygen from the body tissues. Blood pressure will increase as well, due to the increased 
rate of contraction of the ventricles. The blood pressure of the average adult at rest is 
120/S0mmHg.12 The number 120 depicts systole, or the contraction of the ventricles and 
the 80 represents diastole, or the relaxation of the ventricles. 12 This pressure will 
fluctuate during normal cycles of the day and will increase when the body is put under 
stress, such as exercise or perceived psychological stress. 
When the normal human assumes an upright posture, there are several changes in 
the cardiovascular system. First of all, when assuming an upright position, a great deal of 
blood from the thoracic cavity displaces to and pools in the lower extremities.2 For the 
average human, this amounts to between 300mL to 800mL of blood that is displaced 
from the vital organs in the thoracic cavity.14 The body must be able to compensate for 
this sudden movement of blood to the extremities. As Grubb and Karas note, under 
normal circumstances, the body can adjust to this change quickly by slightly increasing 
heart rate to return the blood to the heart. There is little change noticed in the blood 
pressure, because the adjustment is made so quickly by the body.2 In fact, the body can 
usually achieve orthostatic balance (a balance in blood pressure and return to normal 
heart rate) within 60 seconds. 13 The person who has performed the task of standing up 
has no idea that the body has just made this adjustment. The body finds its baseline 
condition and returns to it quickly with out the details of the change ever reaching the 
consciousness of the mind. 
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An increase or decrease in heart rate and changes in blood pressure are not just 
"achieved." There are several body structures that make these adjustments possible. 
First, the heart is constantly under the influence of two types of fibers, which both stem 
from the medulla oblongata in the brain. One set of these fibers causes the heart rate to 
speed up (or stimulate) and is termed the sympathetic branch. 12,13 The other set functions 
as an opposing force to the sympathetic fibers. These fibers are termed the 
parasympathetic fibers and are responsible for slowing down (or inhibiting) the heart 
rate. 12-13 Both the sympathetic and parasympathetic fibers are under autonomic control 
and are therefore are involuntary.12 These two opposing sets of fibers are constantly in 
balance and will adjust to any body changes to remain SO.12 It is this balance that controls 
the heart rate according to the needs of the body. 
The heart also has two groups of nerve cells that help maintain normal blood 
pressure. As Tortora and Grabowski note, the first of these groups are termed 
baroreceptors. The baroreceptors respond to changes in the amount of pressure, or 
stretch, that is being placed on the blood vessels. These receptors constantly monitor the 
amount of pressure being exerted in the arteries, veins and the right atrium. If there is a 
change in pressure, the baroreceptors alert the brain so the proper actions can be taken to 
adjust the body's overall blood pressure. If the blood pressure is low, for example, the 
baroreceptors will notify the brain so the vessels will vasoconstrict to increase pressure. 
The second group of receptors used to control blood pressure is chemoreceptors. These 
receptors monitor the chemical balance in the blood and send messages for it to be 
adjusted accordingly. If more oxygen is needed, as in the case of exercise, the 
chemoreceptors will begin the chain of commands to make this adjustment. 12 
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_ Normally, when a human assumes an upright posture, there is an increase in heart 
rate caused by increased sympathetic activity and peripheral vascular resistance brought 
about by the changes noted by baroreceptors and chemoreceptors.2 All parts of the body 
should get adequate amounts of blood and be able to function normally. In the patient 
with neurocardiogenic syncope, however, this is not the case. Syncope is actually caused 
by a decrease in profusion of blood in the brain.7 If this decrease in profusion continues 
for approximately 8 to 10 seconds, the areas of the brain that are responsible for 
maintaining consciousness do not get an adequate blood supply and the result is 
unconsciousness.7,11 When the neurocardiogenic syncopal athlete displaces blood to the 
lower extremities, it pools just like in a normal person. 14 The syncopal athlete, however, 
does not compensate for the sudden movement of blood. This miscue causes a decrease 
in venous return. 14 Normally, this decrease in venous return should cause an increase in 
heart rate and systemic vasoconstriction of the peripheral blood vessels. 12 The brain of 
the syncopal athlete, however, will get the messages confused. She will experience a 
decrease in heart rate, termed bradycardia, and systemic vasodilation. 14 Both of these 
factors lead to a decrease in cardiac output, which in turn leads to decreased profusion in 
the brain and n~sults in syncopal or presyncopal episodes.3 
At this time, researchers are still trying to discover how the brain confuses the 
messages necessary to keep profusion at appropriate levels. Tortora and Grabowski state 
that beta adrenergic receptors in the skeletal muscles and the heart cause the sympathetic 
message from the brain to stimulate vasodilation rather than vasoconstriction. 12 For this 
reason, many treatments involve using beta-blocking drugs to attempt to prevent this 
reaction.2 This is a challenging question, however, because the body of the syncopal 
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athlete is performing the exact opposite reactions of what it should be.7 Many athletes, 
for example, will say that they feel their heart is not "keeping up with them." It is the 
bradycardia that makes the athlete feel this way.7 They feel that the heart is simply not 
pumping quickly enough to deliver the body cells the oxygen they need to function. 
When the athlete is engaging in physical activity, this can be a very uncomfortable 
feeling, due to the increased need of oxygen from the cells. As the heart continues to 
beat slowly, however, the increase in demand for oxygen causes the heart to increase the 
strength of ventricular contractions, attempting to fill the needs of the cells. 14 This 
increases the discomfort that the athlete experiences. Not only is her heart beating slowly, 
it feels as ifit is pounding inside her chest. No matter how hard the heart pounds, 
however, it is unsuccessfully trying to pump blood from an empty chamber. IS Not until 
the body is able to increase venous return will the heart once again become efficient. 
As for the brain, there is no other choice but to shut the body down to a state of 
unconsciousness. It is not that the brain is in immediate danger, but is taking protective 
measures before the situation gets any worse. Each structure of the brain needs a great 
deal of oxygen to work properly.16 When it does not have the blood it needs, it has to 
shut down the functions that are less important so the areas that need blood to keep the 
body alive can continue to function. 16 In this case, consciousness is controlled by the 
reticular activating formation. When this structure does not receive a proper amount of 
blood, it makes its move to protect the body. Unfortunately, evolution has placed the 
human brain at a disadvantage. Since athletes are almost constantly in a vertical position, 
the blood has to be pumped against gravity to reach the most important organ in the 
body.4 If all functions are not performed exactly as needed, as in the case of the syncopal 
-athlete, that pn::cious blood supply is all too quickly compromised.4 This concept makes 
it easy for both the athlete and the Athletic Trainer to understand that the athlete should 
always lay down on their back at the first signs of an attack.4 This position puts the brain 
in a more advallltageous location so the heart will no longer be forced to work against 
gravity.4 If the attack is recognized quickly and the proper position is assumed, a full 
syncopal episode may be avoided. 
The Prodrome 
Since avoiding full syncopal episodes is the goal with any athlete that has 
neurocardiogenic syncope, the athlete, Athletic Trainer, coach and any of those 
responsible for the athlete must make themselves aware of the signs and symptoms of an 
attack. In most cases, there are a set of signs and symptoms that occur before each 
episode.6 These signs and symptoms include (but are not necessarily limited to) pallor, 
weakness, lightheadedness, yawning, nausea, diaphoresis (excessive sweating), 
hyperventilation, blurred vision, and impaired hearing.6 Some athletes will also complain 
of a numb, tingling feeling in their hands. Collectively, these warning signs of an attack 
are termed the prodrome.7 It is important to note that each individual experiences his or 
her own set of symptoms before each attack.4 The prodrome that one athlete feels will 
not necessarily be the same symptoms that the next athlete will experience.4 It is 
important that the athlete and the Athletic Trainer keep the lines of communication open 
as the athlete gains experience in recognizing the prodrome. Once the athlete has a 
couple episodes, she will see a pattern in how she feels before each attack and will be 
able to recogni7~ those symptoms. 
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Some research has supported the idea that syncopal episodes are preceded by an 
aura sensation. An aura is a short perceptive experience with somatosensory, autonomic, 
psychic or compound content that can occur as part of the prodrome. 17 In other words the 
athlete simply "feels" as if something in the body simply isn't right. For example, the 
athlete may feel some palpitations, which makes them feel as if there is something 
wrong. 1 Some athletes will state that they feel somewhat sick, weak or uneasy several 
minutes before the presyncopal or syncopal episode begins. 17 Some researchers ignore 
the aura phenomenon and consider the idea phenomenon more of a "psychic" reaction, 
but other researchers have found evidence that this phenomenon actually may be 
experienced during the initial moments of a presyncopal episode. 17 Interestingly, this 
type of phenomenon is noted and accepted as an identifying symptom of epileptic 
seizures. 17 It has been thought by some researchers that the absence or differences in the 
types of aura experienced between neurocardiogenic syncope patients and those with ictal 
disorders could be a key to differentially diagnosing syncope, but this has not yet proven 
to be affective. 17 
Neurocardiogenic attacks do not always occur with a prodrome, however.7 Some 
syncopal episodes, unfortunately, will have no warning signs. This type of syncopal 
attack is termed Malignant Vasovagal Syndrome.4 Some athletes will experience 
neurocardiogenic syncope attacks with a prodrome every time, some with no prodrome 
each time and some with a combination of the two. Malignant attacks are very 
dangerous. Since there is no prodrome, the athlete has no idea the attack is coming. The 
athlete could bc~ standing stil~ competing, or even driving when the attack manifests. 
Because of these risks, there is no choice but to treat the patient immediately. Every 
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method possibk~ must be attempted to prevent these malignant attacks. Continuing with 
athletic participation would be considered very risky for the athlete with malignant 
vasovagal syndrome. Malignant attacks could also be a warning sign that there are 
causes other dum neurocardiogenic syncope leading to unconsciousness and should be 
investigated. If the majority of the athlete's episodes are non-malignant, however, the 
risk is much less. The athlete and the Athletic Trainer must simply attempt to prevent as 
many episodes as possible. 
Techniques for Diagnosis 
From the physician's standpoint, neurocardiogenic syncope can be very hard to 
diagnose. One reason diagnosis is frustrating is due to the fact that syncope can be both a 
symptom and a sign.2 In other words, it can be caused by other things, or it can be 
causing other problems. For example, an athlete who presents with syncopal episodes 
could have a he:art condition that is causing the problem. In that case, syncope is a 
symptom. The:re are also several precipitating factors of which syncope is a sign. Some 
of these factors include anemia, dehydration, hunger, recent illness, physical exhaustion 
and too much time trapped in crowded, poorly ventilated areas. 18 Diagnosis of 
neurocardiogenic syncope is also difficult because there are so many possible causes for 
the condition. 14 All possibilities must be explored to ensure the safety of the athlete 
during competition. Unfortunately, in up to 500/0 of patients that present with cases of 
syncope, no actual diagnosis can be made concerning the cause. 19 These cases of 
syncope fall under the ''unexplained'' category mentioned earlier. Finding a correct 
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_ diagnosis in athletes is particularly important. If the athlete feels at all unsure about her 
condition, she will not feel comfortable or safe returning to competition.3 
There are several possibilities pertaining to the cause of syncope. The athlete 
could be experiencing anything from neurocardiogenic syncope to drop attacks, heart 
malfunctions, vertigo, dehydration or even seizures.4 The ftrst objective in evaluating any 
case of syncoJX~, however, is to rule out an underlying cardiac disorder. I I Cardiac 
disorders are the most dangerous cause of syncope and must be identifted as quickly as 
possible. The liest and most vital step in the diagnosis process is the history. The initial 
history, when combined with a physical examination has been found to identify the cause 
of syncope anywhere from 40% to 85% of the time. 6, II Aspects of the history that should 
point the physieian in the direction of a neurocardiogenic syncope diagnosis include 
young age; no previous history of cardiac disease or complications; presence of a 
prodrome; and presence of post-syncopal fatigue. 3 The physician needs to be diligent 
when asking questions about diet, hydration, activity levels, previous history of syncopal 
episodes and family cardiac history. It is also very important that the physician ask the 
athlete speciftc details about all the medications that she is taking.6 In the college athlete, 
it is important to note that lack of sleep and excessive alcohol intake can predispose an 
athlete to neurocardiogenic syncope. II At times, an outside observer, such as a parent or 
the athlete's Athletic Trainer can be helpful during the history portion of an 
examination.20 The outside observer can remember aspects of each episode that the 
athlete may not remember or may not be able to view because he or she is unconscious.20 
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Diagnostic Testing 
The ne)!j step in diagnosing neurocardiogenic syncope is conducting a 
comprehensive physical examination. This should include a complete thorough 
neurologic and cardiovascular evaluation.2o It should look for signs of heart malfunction, 
including orthostatic hypotension or any congenital heart conditions.20 Orthostatic 
hypotesion is a fall of systolic blood pressure greater than 20mmHg or diastolic pressure 
great than 10mmHg after the athlete has assumed and maintained a standing position for 
at least three minutes. 15 As stated before, the physician must be on the lookout for any 
sign or symptom that would lead to a cardiac abnormality. It is also helpful in the 
physical examination if the physician is aware that neurocardiogenic syncope commonly 
occurs in three patterns, each of which has its own physiological marker. 18 The three 
patterns are: 1) vasodepressor type, marked by hypotension; 2) cardioinhibitory type, 
marked by bradycardia; and 3) a combination of both of these types. 18 Knowledge of 
these three patterns and their physiologic markers, when combined with a good history, 
can help the physician come to a better diagnosis of the condition. 
Although ruling out cardiac abnormalities should be first priority when examining 
the syncopal patient, it is also important to rule out ictal disorders, also known as 
seizures. 16 Seizures present themselves in many forms, from an absence seizure to grand 
mal seizures. Some seizures, especially the grand mal seizure and some petit mal 
seizures, are characterized by involuntary movement of the body.16 During some 
neurocardiogenic episodes, these same seizure-like movements can be noted in the 
athlete? 1 If these movements are described by the observer questioned in the athlete's 
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_ history, they must be examined so seizures can be ruled out. One key to differentiating a 
seizure from a neurocardiogenic syncope attack is the experiencing of post-seizure 
confusion.!! Aaer a syncopal episode, the athlete should not experience confusion.6 This 
is not to say that there will not be a period of fatigue, because that is very common in 
neurocardiogenic syncope. 2 1 After a seizure, however, the patient experiences a great 
deal of confusion and has no sense of what has just happened to them and why. An 
athlete who has experienced a syncopal episode, however, should be tired, but alert and 
-
aware. 
The next logical step in the diagnosis of neurocardiogenic syncope is the 
utilization of diagnostic testing. There are several different types of diagnostic tests and 
devices that can be used when diagnosing neurocardiogenic syncope. However, because 
many of these tests can be unpredictable and at time unreliable, the Athletic Trainer and 
team physician must always be on the lookout for differential signs and symptoms. 1 The 
fIrst test used in almost anyone suspected of having a cardiac abnormality is the ECG, or 
electrocardiogram (also known as EKG). An ECG consists of electrodes, termed leads 
(the most commonly used is the 12-lead ECG) and a recorder to read the input from the 
electrodes.!2 These leads are attached to the skin and can pick up electrical currents 
given off by the heart. 12 These currents are then recorded and printed out by the recorder. 
The printout consists of both peaks and valleys, termed waves, that are created as the 
heart beats. 12 An example of what a normal heart beat recording should look like is 
pictured in Appendix B. As you can see, the large peak on the ECG represents the QRS 
Complex, which depicts the ventricular depolarization during contraction. 12 The smaller 
peak after the QRS Complex represents the T Complex and ventricular repolarization 
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during relaxation of the ventricles. 12 The distance from Q to T on an ECG is important, 
because if this interval is longer than normal, this indicates a cardiac problem. This 
problem is termed Long Q-T Syndrome. 12 An athlete with neurocardiogenic syncope, 
however, will usually have a normal ECG. This test, therefore, is necessary to rule out 
cardiac abnormality, but does not help much in the specific diagnosis ofneurocardiogenic 
syncope.20 
Another test commonly used in any patient suspected of cardiac deficiency is an 
echo cardiogram. 20 An echo cardiogram uses an ultrasound machine to view the heart 
beating inside the chest.2o This test is very useful when trying to detennine if blood is not 
flowing through the heart normally for one reason or another. This test can show the 
physician if the: valves are not functioning properly, ifthere is a deformation of the heart, 
or any other defect that would cause the heart to not function properly.20 The results of 
this test are video taped for review by a cardiologist. As is the case with an ECG, this 
test is essential during evaluation of any patient with a suspected heart abnormality. It 
does not, however, show much evidence that would help diagnose neurocardiogenic 
syncope.20 It is a great tool, however, to be sure there are no defects of the heart muscle 
or it's valves. 
As Hammill explains, a third test used in the diagnosis of neurocardiogenic 
syncope is the Exercise Stress Test. This test is mandated if the athlete experiences 
syncopal episodes during or after exercise. The test includes an ECG that is taken as the 
athlete is stressed physically on a treadmill. It also includes repeated blood pressure 
checks throughout the duration of test and during the period of recovery. One important 
aspect to remember about the exercise stress test is that the athlete must be monitored at 
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all times. Iftht! athlete should begin to feel faint, the test must be stopped to avoid injury. 
The athlete should be monitored not only during the activity but during the entire 
recovery period, watching for signs and symptoms of syncope.20 What is interesting to 
note about this test, however, is that it does not reproduce the signs and symptoms of 
neurocardiogenic syncope in most athletes.3 This test, therefore, does not tell the 
physician or the cardiologist anything about the cause of the patient's syncope. In many 
cases, an athlete will be tested in this manner, considered ok, and the cause of syncope 
will go unexplained unless the athlete is unsatisfied and returns for further examination. 
There are several other tests that are geared more specifically to diagnosing the 
syncopal patient who has a noncardiac-based syncopal condition. One of these tests is 
the ambulatory ECG.20 The ambulatory ECG allows monitoring of the heart throughout 
the changes of a twenty four hour period.2o These are conducted with similar equipment 
that is used by a normal ECG, but without all the bulky equipment that can only be used 
in a hospital environment.20 The data is simply recorded and printed out at the end of the 
twenty-four hour period.20 The same limitations would apply to these types of devices 
that would apply to an regular ECG, however. Unless the athlete has an episode during 
the twenty-foW' hour period that the ambulatory ECG is worn, there are no conclusive 
results from this test. They are useful in learning the normal heart patterns that the 
athlete experiences in a normal day?O It can also monitor the effects of standing up, 
walking around and even athletic competition while the athlete participates. 20 
Event recorders, as Hammill explains, differ from the ECG and the ambulatory 
EeG in one major way. The event recorder is only activated when the patient feels it 
necessary to ret;ord the activity of the heart, as during a syncopal episode. These devices 
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-are only capable of recording small amounts of data and storing them to be printed off 
later. Event recorders, also known as memory loop recorders, have electrodes that are 
worn by the patient at all times, except when showering. They are helpful in recording 
episodes that occur on an infrequent basis. One of the latest advances in event recorder 
technology, however, is the invention of implantable loop recorders. These devices are 
implanted subcutaneously in the upper left chest and are as small or smaller than a credit 
card. A "beep(~r" that the athlete carries with her at all times activates the device. The 
major advantage to these new implantable recorders is that the athlete can go anywhere 
and do anything while this device is in the chest. Activities like showering are not a 
problem and the athlete can activate the recorder at any time. The device can also be left 
in the chest for a prolonged period of time. 20 
All of the above tests and devices are good to rule out cardiac conditions that 
would cause syncope. There is a test, however, that is specifically designed to diagnose 
neurocardiogenic syncope in its true form. This diagnostic test is termed the tilt-table 
test. The most important aspect of the tilt-table test is that it can actually reproduce the 
symptoms ofn4~urocardiogenic syncope in the laboratory setting.2 In fact, tilt-table 
testing is just like spontaneous syncope because the same prodrome can be experienced 
in both instances.2 This reproduction of both the prodrome and the episode give the 
clinician a chance to see what actually happens to the athlete during a syncopal episode. 14 
Tilt-table testing requires the athlete to fast overnight before performing the test. 14 The 
athlete is placed supine on a table with a weight-bearing footboard to help support the 
body.14 The table is then slowly tiled to a certain angle and held there until the athlete 
experiences an syncopal episode. 14 A picture of this procedure can be found in Appendix 
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C. During the duration of the test, the athlete's blood pressure, ECG and sensations are 
all being monitored. You will notice if you look at Figure 2 in Appendix C that the heart 
can be seen slowing into bradycardia and in most patients will even reach a period of 
asystole.5 The amount of tilt ofthe table is controversial. The American College of 
Cardiology recommends tilting to an angle of60 to 80 degrees for 45 minutes.4 At times, 
an intravenous infusion of isoproterenol is used to help provoke the syncopal episode if a 
fIrst tilt is unsuccessful. 14 
There are five broad groups of reactions to tilt-table testing as researched by 
Grubb, Karas and Kimmel. The five reactions are as follows: 
1. Classic Neurocardiogenic Response: A sudden drop in blood pressure 
followed by a decrease in heart rate. 
2. Dysautonomic Response: A gradual decrease in blood pressure until 
hypotension causes unconsciousness. 
3. PoSitural Orthostatic Tachycardia Syndrome: Low peripheral vascular 
resistance that the body attempts to correct with tachycardia. 
4. Cer.~bral Syncope: A rare condition that involves vasoconstriction in the brain 
only. 
5. Psyehogenic or Psychosomatic Response: No change in blood pressure or 
hemt rate. The patient usually has a psychiatric disorder in this case. 
These reactions to tilt-table testing can give the cardiologist clues to the exact mechanism 
causing the athlete's syncopal episodes.2,14 
Tilt-table testing, like any other test in medical examination, is not perfect. There 
is a possibility that the athlete will show a false-positive or even a false-negative reaction 
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to tilting. There are several reasons for a false reporting test. First of all, the test may be 
performed improperly. Research has shown that if the patient is tilted less than 60 
degrees, she may not show symptoms because the tilt was not steep enough. 5 The athlete 
could also lose consciousness simply from fear or just from the tilt of the table without 
having any underlying condition. Interestingly enough, highly trained athletes will 
sometimes have a false-positive reaction to the test.7 It is important to follow up with 
these patients a. couple of times to be sure the test was positive. This can be hard, 
however, because the test itself is an unpleasant experience, especially if the athlete 
experiences syncope?2 Most athletes that experience syncope during vigorous exercise 
will have an abnormal reaction (or positive result) to the tilt-test, however, making it a 
very effective diagnostic too1.9 
Effects on Daily LivinglParticipation 
Once the physician and the cardiologist have administered all applicable 
diagnostic tests and have ruled out all other possibilities, they will come to the conclusion 
that the athlete has neurocardiogenic syncope. The most important thing for the athlete to 
remember at this time is that this condition is NOT life threatening!3 In fact, According 
to physicians, it is safe for athletes with exercise-related neurocardiogenic syncope to 
continue to participate.9 What the athlete, coach and Athletic Trainer all need to be 
concerned with, however, is the risk of secondary injury during episodes. In many cases, 
the athlete will feel a prodrome, but will continue to push themselves due to internal 
competitive drive or to keep their spot on the team. This is often true in collegiate 
athletes. If the athlete continues to ignore the signs ofan episode, however, they are more 
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- likely to faint while running down the court or field. These falls can become dangerous, 
because they Clm result in trauma to the face, skull, and extremities. 14 Not only is there a 
risk when athle:tes are on the playing surface, but there are dangers of episodes and injury 
when in the workplace or when driving a vehicle?1 These dangers must be reviewed and 
understood by the athlete as soon as the diagnosis is made.21 
-
In all cases of neurocardiogenic syncope, it is important that the physician address 
the subject of driving a motor vehicle. The decision to allow an athlete with 
neurocardiogenic syncope to drive is a complicated matter.23 According to Miles, there 
are several questions that the physician needs to ask both himself and the athlete. Some 
of these questions are: What is the risk of harming other drivers? What level ofrisk is 
appropriate in today's society? How severe are the events and how long before the event 
does the prodrome begini9 When asking these questions, it is important that the 
physician remember that the goal of reaching zero risk for both the athlete and other 
drivers is unobtainable.29 There is no possible way, even with treatment that the 
neurocardiogenic syncope patient can be 100% safe when driving. The athlete and the 
physician need to assess the risk and decide if driving is worth the trouble?9 The same 
idea applies when allowing the athlete to participate in high contactlhigh risk sports. 
There would lx~ more risk, for example, to let the athlete play football than to play tennis. 
The table in Appendix D gives examples of the possible risk associated with many 
popular sports. 
Although neurocardiogenic syncope is not life threatening and does not cause a 
great deal of physical impairment, there is a great deal of psychological impairment that 
the athlete (or any nonnal patient with the condition) must deal with. 19 Syncope can 
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_ often get in the way of a normal lifestyle. In fact, some studies have shown that up to 
seventy-six percent of subjects state that syncope interferes with their activities of daily 
living.19 The athlete constantly has a fear of having a syncopal event looming just above 
them. This constant worrying about the condition leads to a great deal of morbidity. 19 
Morbidity describes how limiting the illness or condition is to daily life, not how likely 
one is to die from the condition (mortality). In fact, this condition has a very low 
mortality rate, but a high morbidity rate.s It is the fear of the episode that makes living so 
hard.8 Imagine walking around being afraid to participate in any activity that may stress 
the body because you fear syncope. It is hard to imagine. In fact, some studies show that 
even the physi<:ian can not understand how impaired the syncopal athlete really feels. S 
This lack of empathy probably stems from the point of view that the physician uses 
compared to the athlete. The physician tends to see mortality only, whereas the athlete 
will usually only see the morbidity.19 . Appendix E contains a functional status 
questionnaire that is commonly used to assess the impairment of patients. 
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Preparticipation Screening 
In the athletic arena, the most effective solution for problems presented by 
neurocardiogenic syncope is prevention and proper screening for the condition. In many 
cases, athletes with neurocardiogenic syncope will not make it to the elite intercollegiate 
level because they are ''weeded out" in the recruiting process. It is important, however, 
to screen all athletes as they enter the facility to prevent putting their lives in danger. The 
screening can be accomplished in the preparticipation physical. The purpose of this 
screening is to provide medical clearance for participation in all aspects of competitive 
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sport by using systematic evaluation.23 These evaluations will check orthopedic stability, 
past history of injury or illness and will give a sketchy idea of cardiovascular health. A 
current debate in institutions all over the United States, however, argues whether or not 
athletes should have a comprehensive preparticipation cardiac screening before being 
cleared to participate. The goal of this type of screen would be to identify athletes with 
unsuspected heart disease that could predispose them to sudden cardiac death. 1 
When designing a preparticipation cardiac screening, there are several items that 
must be kept iIll mind. First, screenings should be designed by taking into account that 
sudden cardiac death in athletes is very rare. 23 More than likely, the physician will not 
fmd any problems with the athlete. The physician should take a good medical history, 
including family history, history of chest pain, palpitations or irregular heart beats and 
syncope. I This cardiac screening should fit in with the rest of the preparticipation 
physical. Interestingly enough, universally accepted standards currently exist for this 
screening.23 If the athlete's initial history and physical examination lead the physician to 
believe that a problem may be present, further diagnostic testing should be ordered. 
Diagnostic testing, history and physical examination, no matter how well they were 
performed, are not going to be able to catch every condition.23 As with driving, there is 
never going to be a situation where there is no risk. 23 The athlete must realize that by 
participating in organized sports, there is always a chance for injury or even death. 
The major limitation of the preparticipation cardiac screening is not the 
unwillingness of the physician to perform the tests, but rather the high cost of common 
cardiac screening procedures. The athletic popUlation, especially at the college level, is 
relatively healthy. Most of the cardiac screens, therefore, would cost a great deal but not 
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-yield any usefu.l results. I Take, for example, the ECG. When given alone, the ECG is a 
fairly inexpensive test.! When a Division I university would perform the test on all of its 
athletes, however, the cost would quickly mount up. (Many large universities have as 
many as 800 athletes to screen!) Also, an ECG that shows an abnormality must be 
followed up with another test. I Since fmding an abnormality is fairly common, the cost 
of screening every athlete skyrockets. The cost for ECG testing alone can go anywhere 
from $400 to $2,000 per test.23 It is obvious to see why this type of screening would be 
impossible for schools with small budgets. Some larger schools (large Division I 
schools, for example) are able to get the procedures necessary for cardiac screening 
donated from ac local hospital. The hospital exchanges its services and use of equipment 
for affiliation with the university. This is still very unique, however, and is not 
commonly seen. 
Legally speaking, it is expected that in our society that the physician make a 
prudent effort to minimize as much risk as possible for the athlete.23 When an athlete is 
examined by the physician, she expects the physician to perform her examination to the 
best of his ability. It is also expected that every athlete that is given a physical is given 
one of equal quality.23 Because a comprehensive cardiac evaluation is usually too 
expensive to be performed, however, where is the line drawn for the amount of risk the 
physician is aClcountable for? As Maron, Thompson, Puffer and others state, the 
physician who has provided cardiac clearance for an athlete to participate in athletics is 
not liable for any undiscovered cardiac condition. For the athlete to win a malpractice 
suit against the physician, she would have to prove that the physician deviated from the 
customary practice that any prudent medical professional would have used.23 In other 
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words, if the physician performed the athlete's screening according to the standard of 
care established by the facility where he is performing the screen, he is not liable. It is 
important the physician be thorough in their examinations and pay close attention to 
every detail to protect the athlete and himself 
Treatment Options 
When an athlete is diagnosed with neurocardiogenic syncope, the Athletic Trainer 
and the physician should do everything within their scope of practice to keep the athlete 
in competition. Neurocardiogenic syncope can be very hard to treat, however, and not 
every athlete will be able to fully return to participation.7 The basis of all treatment 
protocols is th<:: idea that the triggering mechanisms for neurocardiogenic syncope 
episodes can b~ prevented. 5 Many episodes can be prevented by knowing the signs and 
symptoms of the prodrome and using common sense to avoid a complete syncopal 
episode. The goal of a treatment program should be to find a way to improve the quality 
of the athlete's life. Treatment protocols aim at avoiding as many recurrences as 
possible?4 When there are less recurrences, the athlete does not have to worry about 
syncope so much and can spend time on other things. This improves the quality of the 
athlete's life. As stated before, however, treatment is not easy. Each protocol must be 
tailored to fit the athlete and adjusted until the right solution is found? 
One option for treatment is the use of pharmacotherapy. 14 This treatment option 
is chosen often and is very popular. It is easy to get caught up in the use of drugs as a 
cure-all solution, however. Most guidelines, on the other hand, suggest that 
pharmacotherapy is required to stop recurring episodes that are disrupting normal daily 
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- activity.14 The most popular classification of drugs used to prevent syncopal episodes are 
beta-adrenergic: blocking agents?2 Beta-blockers reduce the output of the heart at rest 
and during exercise.25 They reduce exercise heart rate and blood pressure.25 In short, 
these drugs are able to decrease the workload of the heart both at rest and during exercise. 
It is the goal of these drugs to make it easier for the heart to keep up with the body during 
exercise, preventing decreased venous return.22 Not every athlete responds well to beta-
blockers, however. Older athletes commonly have better responses to beta-blockade.26 
In some patients, these drugs can actually make the condition worse?6 The side effects 
of these drugs are also hard for some athletes to bear. Beta-blockers are notorious for 
making the athlete feellathargic and nauseous, both of which can negatively affect 
performance.25 The drugs are also known to cause bradycardia at rest, which is 
bothersome and uncomfortable for some athletes.27 The most important side effect to be 
aware of, howc;:ver, is that beta-blocking agents can mask the symptoms of low blood 
sugar and must never be prescribed to diabetic athletes.25')7 Two commonly used beta-
blockers are Altenolol and Pindolo1.25 
There are several other drug classifications that can be used to treat 
neurocardiogenic syncope. Some physicians will choose to use antiarrhythmic agents, 
which are used to help control or prevent irregular heat beat patterns.25 A commonly 
used antiarrhythmic drug is Norpace.25 To understand the pharmacology, however, one 
must be well vt~rsed in how several classifications of drugs work and how they all react 
together. It also has been found in many cases that a combination of cardiac drugs is 
effective in small doses, instead of using one drug at a high dose? It is the job of the 
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__ cardiologist or physician to know the medications, their dosage levels, indications and 
contraidications so a safe balance can be found for each individual athlete. 
-
It is important that the physician monitor the athlete closely when using drugs to 
control syncope. He must watch how the athlete is responding to the drugs and 
constantly adjust the prescriptions to match the needs of the patient. In most cases, it is 
recommended that pharmacotherapy be discontinued after one year.3 If the athlete's 
condition worsens after ending treatment, however, they should be returned to the drug. 
If there is no change, drug therapy can be discontinued permanently. The prescribing 
physician must also be aware that some drugs that are used for treating neurocardiogenic 
syncope are listed as being banned by the NCAA.7 These drugs must be avoided if the 
athlete is going to continue participation. Contrary to popular belief, most syncope drugs 
are not banned due to their ability to enhance performance, but rather their ability to blunt 
performance.7 For example, the athlete who is lethargic from taking a beta-blocker will 
not be able to respond as quickly as normal, which may lead to injury. 
A new and somewhat controversial alternative to treatment has been noted in 
recent research. This treatment involves repeated and prolonged exposure of the body to 
gravitational stress, much like that which is experienced during a tilt-table test.28 This 
treatment subje:cts the athlete to repeated tilt-table testing. At each visit, the test is 
performed until the 45 minute time limit is up, or the athlete has an episode of syncope. 28 
When not in the laboratory, the subjects were instructed to lean their upper backs against 
a wall for 30 minutes twice daily.28 Standing in this position is supposed to simulate a 
tilt-table situation.28 The last part of this treatment involved sleeping in a head-up tilted 
bed (using extra pillows, for example).28 The idea behind this treatment is to attempt to 
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continually expose the athlete to situations in with the orthostatic balance is 
compromised?8 It is believed that this repeated exposure will help the body "get used to" 
the condition and lessen the chances ofa dramatic systemic reaction. If the body 
responds less dramatically, the athlete will have less episodes of syncope. In fact, in a 
study done by Ector, Reybrouck, Heidbuchel and others, all subjects in the study ended 
up free of syncope with out the use of any pharmocologic therapy. This treatment 
protocol can also be carried out without using multiple tilt-table tests. The therapy can 
simply be perfi)rmed at home against a wall, using another person to help support the 
participant should she experience syncOpe.28 
Another controversial treatment for neurocardiogenic syncope is permanent 
atrioventricular pacing.5 This involves putting a pacemaker in the heart and using it to 
control the heart's rhythm.5 Amazingly, however, most studies show that this treatment 
has little or no ability to prevent neurocardiogenic syncope. In fact, in one study, 21 out 
of22 consecutive patients who showed significant bradycardia during a tilt-table test had 
no success with permanent pacing.5 Pacing is a very invasive treatment, and is a 
treatment that will effect the patient for the rest of his or her life. It should only be 
considered as a last resort.5 More research on pacing needs to be done, however, to 
determine its tlUe effectiveness. Most researchers agree that the benefits (or drawbacks) 
of pacing have not been determined. The success of pacing is also very patient specific, 
so the cardiologist and the patient must both agree to the procedure. 
One of the most important aspects of any treatment protocol for neurocardiogenic 
syncope is to educate the patient about the condition. Calkins feels that educating the 
athlete can not be underestimated. He suggests teaching the athlete situations in which 
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neurocardiogenic syncope is most likely to occur and how to avoid them. He also 
suggests teaching the athlete the importance of lying down as soon as she senses 
prodromal sYl11ptoms.3 As stated earlier, if the athlete can learn to use common sense, 
many episodes can be avoided. In many cases, the cardiologist performing the athlete's 
ftrst tilt-table test will provide a good deal of education to the athlete. For this reason, 
many athletes will see a great deal of improvement shortly after the test. 4 It could also be 
that the athlete is reassured by the cardiologist who performs the test. He or she will 
know a great deal about the condition and will be able to share this information with the 
athlete. 1o Some studies have even shown that not treating the athlete at all may be more 
effective than any other method of treatment. 4 Treating the athlete with education only 
involves less risk, but may not be practical for the intercollegiate setting. 
The athlete with neurocardiogenic syncope also needs to be educated on how to 
lead a healthy lifestyle. Many athletes, especially those at the collegiate level do not 
know how (or do not take the proper time) to take care of their bodies. They do not get 
enough sleep, consume too much alcohol and do not eat healthy diets. It is suggested that 
the athlete with neurocardiogenic syncope should eat at healthy diet and increase sodium 
intake to at least 3 grams per day.3 The athlete's syncopal condition and their general 
health will improve with a little counseling. On the collegiate level, the Athletic Trainer 
can provide a great deal of support to the athlete in this area. In fact, many college 
Athletic Trainers have access to the services of nutritionists and psychologists that may 
be able to assist the athlete in forming good habits. This education in supplement to other 
treatment may help the athlete wash neurocardiogenic syncope out of her daily life. 
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_ Giving the athlete confidence that she can overcome the condition may also be one of the 
most powerful tools the Athletic Trainer or physician may be able to give the athlete. 
Conclusion 
Neurocardiogenic syncope is a fairly new condition in intercollegiate athletics. 
The Athletic Trainer, team physician and coach must be constantly aware of the health 
and safety of the neurocardiogenic syncopal athlete. The Athletic Trainer must have a 
working knowledge of the anatomy and physiology of the cardiovascular system and its 
components. He or she must also know the warning signs and symptoms associated with 
a syncopal episode. At times, being able to make the correct referrals is one of the most 
important skills an Athletic Trainer can possess. Knowing the signs and symptoms of 
syncope can be the key for the Athletic Trainer to recognize a serious condition that 
needs to be referred. A working knowledge of the diagnostic testing and treatments of 
neurocardiogenic syncope can allow the Athletic Trainer to become more involved with 
the treatment of the athlete. 
On the intercollegiate level, the Athletic Trainer must be aware of any and all 
conditions that may slow the athlete down. Especially on the Division I level, the 
Athletic Trainer will be held at least partially accountable for the athlete's playing status. 
Knowing the condition, the limitations that the athlete will experience, and ways to 
modify performance and life style will allow the Athletic Trainer to give the athlete the 
best health care: available. The purpose of this examination was to explain the 
presentation, re'cognition, anatomical and physiological concerns, prodrome, diagnostic 
techniques and testing, effects on daily living, preparticipation screening and treatment 
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-- options associated with neurocardiogenic syncope. This examination, however, only 
"scratches the surface." The following case study will also provide a realistic example of 
the limitations and possible clinical course of the neurocardiogenic syncopal athlete. 
Hopefully these tools can be utilized to prevent fear of a virtually benign condition, 
provide knowledge and stimulate research that will benefit future athletes. 
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Neurocardiogenic Syncope in a Collegiate Basketball 
Player: 
A Case Study 
33 
Personal Data: 
This case presents a 19 year old female intercollegiate basketball player. The 
athlete has not'ed no previous history of physical problems according to her pre-
participation physical exam. She is apparently healthy and has no history of heart disease 
in her family. At the onset of the illness, she was in her fIrst season of intercollegiate 
participation. 
Physical Signs and Symptoms: 
The athlete first presented with symptoms while lifting weights during a pre-
season conditioning session for the 1998-99 competitive season. Her symptoms included 
lightheadedness, diaphoresis, nausea, increased heart rate and pallor. The athlete 
described feeling as if she was going to faint, although a full syncopal episode was not 
attained. After the episode, the athlete complained of feeling "groggy" and very tired. 
She did not state being confused, and she was aware of her surroundings. This condition 
continued for approximately 20 minutes. After this time, she still felt tired, but was able 
to return to her residence. She did state that she had experienced this type of episode 
during her high school career, which was not noted on her pre-participation physical. 
As pre-season conditioning continued, the athlete proceeded to have episodes of 
pre-syncope with much the same prodrome. She eventually experienced a full syncopal 
episode while running on an outdoor track. The athlete was fully unconscious for a 
period of about one minute, and then semi-conscious for approximately an additional two 
to three minute:s. Again, the athlete experienced diaphoresis, lightheadedness, a racing 
heart rate, and other aspects of the prodrome that she had experienced during the 
presyncopal episodes. Also noted by the Athletic Trainer was a period of post-syncopal 
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fatigue. The thtigue lasted for at least 20-30 minutes before the athlete felt well enough 
to go home. 
As the season progressed, the athlete continued to have episodes. At times, the 
Athletic Train(:r or the athlete could recognize the prodrome before the episode. Ifthis 
was the case, the athlete could be strategically positioned to prevent a full syncopal event. 
She was unabh:: to compete or participate in any activity fully, and required a longer rest 
period than the: other athletes between activities. She had episodes during exercise, after 
exercise, when under stress or experiencing emotional challenges, when in pain and at the 
sight of blood, to name a few precursors. During each episode, the Athletic Trainer noted 
an increase in heart rate as the episode started which fell very quickly as the condition 
progressed. The athlete could also be seen checking her pulse at the carotid artery or 
shaking her hands (a sign that her hands were ''tingling'' due to lack of blood flow) before 
each episode could occur. The Athletic Trainer and coaching staff had to be constantly 
aware of the athlete's presence in an attempt to prevent secondary injury from loss of 
consciousness. 
Differential Diagnosis: 
After the first couple presyncopal episodes and the discovery of the athlete's 
previous histOIY of episodes, the athlete was referred to a team physician and a 
cardiologist. liller a great deal of testing, the athlete was diagnosed with 
neurocardiogenic syncope. This diagnosis could not be made until all other conditions 
and abnormalities were ruled out. The physicians and cardiologists where careful to rule 
out underlying cardiac abnormalities, arrhythmia and electrical conduction problems of 
the heart and cardiovascular system. 
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Results of Diagnostic Imaging/Laboratory Tests: 
Testing for heart abnormalities was first performed by the athlete's cardiologist. 
The athlete was subjected to a battery of tests including an ECG, echo cardiogram and a 
treadmill stress test. All of these tests showed no cardiac problems or heart 
abnormalities, so the athlete was cleared to play. When the symptoms continued to 
worsen, however, the athlete was referred for a tilt-table test. This test was the only tool 
able to reproduce the athlete's symptoms. Not only did the athlete have a full syncopal 
episode during the test, but was recorded as reaching a period of asystole. This test 
confIrmed the diagnosis of neurocardiogenic syncope. 
With the diagnosis confirmed, the athlete was subjected to several other tests to 
attempt to find an effective treatment. The most significant of these tests was the 
implantation of a subcutaneous memory loop recorder. The device was placed in the 
athlete's upper left chest and was accompanied by a "beeper" that served as the activating 
device. The athlete was to wear the device at all times and was to activate the recorder 
during an episode. The recorder was capable of recording an ECG reading for a period 
12 minutes before activation and a few minutes after. 
Clinical Course: 
As stat.~d earlier, this athlete had to be constantly monitored. She could have an 
episode at any time. She was first placed on Altenolol (a Beta-Blocker) and her activity 
was monitored. There were attempts to modify her caffeine intake, sodium intake and to 
improve her diet. None of these treatments seemed to help, however, and the condition 
continued. Despite readings from the loop recorder and attempts to change her 
medications, the athlete did not see much improvement. She attempted to continue with 
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,~ another year of intercollegiate participation, but was unsuccessful. She eventually chose 
to leave the team in an attempt to get a better control over her syncope. The athlete did 
have a period where the condition appeared to be improving, but she continues to have 
problems at th~ present time. She states that the condition "comes and goes" for 
extended periods. Her cardiologist is also considering the use of permanent pacing to 
attempt to control the condition. 
-
Deviation from Expected: 
There are several deviations from the normal with this athlete. First of all, she has 
not seen any n:al improvement in her condition, despite education and treatment. It has 
been approximately one and a half years since her diagnosis, and her doctor is now 
considering pacing. Despite all attempts to adjust the athlete's nutrition, lifestyle and 
medication, she continues to have episodes. At this time, the athlete is very frustrated 
with the condition and states that she will try almost anything if she could stop the 
episodes. 
What is also important to note in this case is the fact that the athlete did not note 
any problems or abnormalities involving syncope on her preparticipation physical upon 
arriving at the university. It is unknown if a preparticipation cardiac screening would 
have caught th~ condition. In fact, a cardiac screen would have included an EeG and an 
echocardiograrn, both of which were negative in this athlete. This case illustrates that it 
is imperative that the athlete notifies the Athletic Training staff of any pre-existing 
conditions. This could have lead to a more timely diagnosis of the athlete's syncope. 
The most important fact to note in this case, however, is that the athlete is no 
longer able to participate in intercollegiate athletics. Her attempts to do so were 
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-- unsuccessful, however, due to her decreased ability to meet the physical demands 
necessary to p.~rform on the Division I level. The athlete is able to play on her own at 
this time, but has trouble finishing a game. Despite a great deal of research stating that 
neurocardiogenic syncope patients can participate in athletics, it is case specific. This 
athlete can only participate at about half of her normal capacity. The athlete does deserve 
credit for giving her best effort, but to play on the intercollegiate level with her amount of 
disability was not feasible. The quality of life for this athlete has greatly decreased, and 
her amount of morbidity often keeps her from living the type of life she would like to. 
There is hope that she will be able to fmd a treatment to control her condition, but she 
will most likely live with it for the rest of her life. 
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Appendix A: 
_Blood Flow Through the Human Heart 
-
-• 
Figure 20.6 Blooe flew through the pulmonary and systemic circulations. 
~ Blood flowing throug.1J lung capillaries loses CO2 and gains 02; blood flowing through systemic capillaries loses 02 and gains COr 
F'orltal ;Jlane 
:hrolJgh heart 
i HEAD AND UPPER LIMBS I 
: TRUNK AND LOWER LIMBS ~ 
(a) Path of blood flow through the heart (frontal section) 
I LEFT I LUNG 
o In pulmonary capillaries. blood 
loses C02 and gains O2 
o t ·~~lmOn~ry t;:;;~ -. ;~'d 
eew~ 
t . Pulmonary semilunar valve 
°.1 
\ 
1 
o 
o 
I 
Right ventricle 
t 
Tricuspid valve 
I 
Right atrium 
(deoxygenated blood) i 
1 
-------------,----)t'.~ 
o ..... ~. ~~J.~~> ~.: '~' .. ' ::~ 
I 
Bicuspid valve , 
o 
I 
Aortic semilunar valve 
• ~ *:;: t};;;, C~~ OS 
~~" 1",., blood j 
loses O2 and gains CO2 
(b) Diagram of blood flow 
Tortora GJ, Grabowski SR. Principles of Anatomy and Physiology. New York, 
NY:Harper Collins College Publishers; 1996:587. 
AppendixB: 
A Normal ECG Recording 
--
Figure 20.10 Electrocardiogram or ECG (Lead II). 
~ An leG is a recording of the electrical activity that 
.,.,., accompanies each heartbeat. 
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Normal ECG of a single heartbeat 
MEANING OF ECG WAVES 
P wave = atrial depolarization 
QAS complex = onset of ventricular depolarization 
T wave = ventricular repolarization 
J 
0.8 
Tortora GJ, Grabowski SR. Principles of Anatomy and Physiology. New York, 
NY:Harper Collins College Publishers; 1996:593. 
Appendix C: 
Tilt Table Testing 
-
--
-
Figure 1 
Figure 2 
2 A, 
, 
. 
.. 
r " I---~---_£_-~---------------------
I 
---------i ___ ..: _________________ _ 
Figure 1. Head-uprighlUII table testing. Procedure begins with patient supine. and table is slowly 
tilted uprighllo 70· angle. 
(Syncope) Asystole: 5.5 seconds 
s 
I'IIC., 
rT'11 1 11 IT~ 
mm 
TILT I') os 70 70 
TIME I') = +0.5 +14 
HR (bpm)= 80 48 
BP (mmHg)= 1251 eo 90150 ( Syncope) 
(a ... lln. ) 
I. Grubb BP. Kimmel S. Head upright tilt table testing. Postgraduate 
Medicine. 1998; 1 03(1): 136. 
Asystole: 9 seconds 
2. Sra JS, Jazayeri MR. Dhala A. and others. Neurocardiogenic syncope: diagnosis. 
mechanisms, IUld treatment. Cardiology Clinics. 1993; II (I): 188. 
r t2' _ 100 J ,. I 10 • .. 0 
AppendixD: 
Possible Risk Involved in Popular Sports 
-
-1. Low static 
II. Moderate static 
III. High static 
A. Low dynamic 
Billiards 
Bowling 
Cricket 
Curling 
Golf 
Riflery 
Archery 
Auto racing*t 
Diving*t 
Equestrian .. t 
~Iotorcycling*t 
30bsledding*i-
Field events I throwing) 
Gymnastics*t 
Karate/judo" 
Luge*t 
Sailing 
Rock r.limbing*t 
Waterskiing*t 
Weight liftin~t 
Windsurfing*t 
.. Danger of bodily collisioJ:l.. 
t Increased risk if syncope occurs . 
TABLE 4 
Types of Exercise by Sport" 
B. Moderate dynamic 
Baseball 
Softball 
Table tennis 
Tennis (doubles) 
Volleyball 
Fencing 
Field events (jumping) 
Figure skating* 
Football (American)" 
Rodeoing*t 
Rugby* 
Running (sprint) 
Surfing*t 
Synchronized swimmingt 
Body building*+ 
Downlull skiing*t 
Wrestling" 
C. High dynamic 
Badminton 
Cross-country skiing (classic technique) 
Field hockey* 
Orienteering 
Race walking 
Racquetball 
Running (long distance) 
Soccer* 
Squash 
Tennis (singles) 
Basketball" 
Ice hockey* 
Cross-country skiing (skating technique) 
Football (Australian rules)" 
Lacrosse" 
Running (middle distance) 
Swimming 
Team handball 
Boxing* 
Canoeinglkayaking 
Cycling*t 
Decathlon 
Rowing 
Speed skating 
.. Reprinted with permission from the American College of Cardiology (Mitchell et aI., J A.m Coll Cardiol 28: 845- 899, 1994). 
Basilico Fe. Cardiovascular disease in athletes. Am J Sports Med. 1999;27( 1): 118. 
-AppendixE: 
S,yncope Functional Status Questionnaire 
Syncope Functiond/.Slalus Questionnaire 
First Name: Hospital 10 
I) Please: answer the following as: Y for ye:s, N for no, or N/ .... for non·applicable:. 
These episodes atIe:ct my life: and daily routine by: 
( ___ ) interfering with my life: or routine: 
( ___ ) preveming or causing me to avoid driving a ve:hicle: 
( ___ ) re:ducing the: amount of walking I do each day 
( ___ ) interfering with my use of public transportation (buses, trains, etc.) 
( ___ ) interfering with my performing errands (grocery shopping. houseke:eping) 
( ___ ) interfering with my physical activities (entertainme:nt, sports) 
( ___ ) atIecting my ability to work at my job 
( ___ ) affecting my relations with my spouseJboyfriendigirlfrie:nd 
( ___ ) affecting my relationship with my family 
( ___ ) affecting my relationships with my friends 
( ___ ) affecting my sexual functioning 
,: .. :... .--, 
... ~.' ~ . 
." 
"' . .... ~ . 
II) How much do you worry about your episodes? On the scale be:low, circle the number that fits you. 
1 2 3 -4 5 6 7 
.-\11 I do is worry 
Ill) How much do you fear a typical episode coming on? On the scale below. circle: the number that fits you. 
I 2 3 -4 5 6 7 
I lIIl terrified neutral 
IV) How does worry about an e:pisode affect your daily life? On the: scale: below, circle the: numbe:r that fits you. 
1 2 3 4 5 6 7 
8 
I never worry 
8 
I have: no fear 
8 
.-\11 I do is worry. so worry totally keeps me: from my routine: I neve:r worry, so worry doe:s not interfere 
Directions for scoring tho:: Syncope Functional Status Que:stionnaire: 
The Impairmem Sccre is computed as the percentage: of applicable areas out of 11 for which the: patient reports that syncope 
affects him or her. For instance. if a patie:nt is unemployed. making the: "work at job" item not applicable:. the score: would be 
based upon ten items. If the patient answered yes to three of those ten, his or her score would be 30, or 30%. The Fear/Worry 
Score is based upon the average of the: three Likert items after they are: rescaled to range from 100 to 0 instead of 1 [0 8.' For 
instance. if the patient answers 2. 6. and 3 to the three questiOns, respectively, these would be rescaled to 85. 7 , 14.3, and 71.4, 
and averaged [0 give a Fc:arlW'orry Score: of 61.9. (Note that it would be more efficient to average the three Likert values bdore 
rescaling. ) 
The Syncope Dysfur.:ction Score (SOS) is the average of the Impairment Score and the FearlW' orry Score. For the hypothetical 
patient noted above, the SOS would be 46. 
"The rescalin~ formula :5: 
100 x (8 - Ukert v2.luc) 
7 
Linzer M, Gold DT, Pontinen M, and others. Recurrent syncope as a chronic disease. J 
Gen Intern Med 1994;9:186. 
